Neuroendocrine Tumors Market Driven by Growing Demand for Targeted Therapies
The Neuroendocrine Tumors Market encompasses advanced therapeutics designed to diagnose, manage, and treat neuroendocrine neoplasms using somatostatin analogs, peptide receptor radionuclide therapy (PRRT), targeted small­molecule inhibitors, and immuno­oncology approaches. These products offer significant advantages over conventional chemotherapy, including enhanced specificity, reduced...
0 Comentários 0 Compartilhamentos 101 Visualizações 0 Anterior